July 2026 in “Quality in Sport” This review reports that Janus kinase inhibitors and regenerative therapies, such as exosomes and platelet-rich plasma, significantly improve scalp hair regrowth in moderate-to-severe alopecia areata, though challenges like high relapse rates and socioeconomic barriers remain, underscoring the need for personalized treatment protocols.
June 2026 in “Preprints.org” This study examined the current clinical practices for diagnosing and managing alopecia areata in Poland, finding that patient care is inadequate and falls short in using validated severity tools and providing access to advanced therapies despite the availability of new medications like Janus kinase inhibitors.
May 2026 in “Reactions Weekly” Finasteride and dutasteride may increase the risk of suicide and sexual dysfunction.
April 2026 in “Canadian Medical Association Journal” This study reported that androgenetic alopecia in women becomes more prevalent with age, with risk factors including heredity and endocrine disorders, and differs clinically from male-pattern hair loss by causing diffuse hair thinning rather than loss at the temples or crown.
April 2026 in “JURNAL ILMU KEDOKTERAN DAN KESEHATAN” In this study conducted among students aged 15-17 at SMAN 7 Tangerang Selatan, researchers found no significant link between nutritional status and the occurrence of telogen effluvium, suggesting other factors like hormonal imbalances or psychological stress may be more influential.
April 2026 in “Portuguese Journal of Dermatology and Venereology” This review summarizes the various skin manifestations linked to COVID-19 infection, vaccination, and personal protective equipment, highlighting their clinical importance and discussing psychological stress and social isolation as additional dermatologic factors.
March 2026 in “Ukrains kyi Visnyk Psykhonevrolohii” In this study, female patients with mixed alopecia reported significantly lower quality of life compared to those with metabolic alopecia, with poorer psychological well-being and personal fulfillment, linked closely to mental maladaptation severity, suggesting a biopsychosocial treatment approach.
March 2026 in “Anais Brasileiros de Dermatologia” Facial aesthetic procedures improve quality of life for transgender individuals.
February 2026 in “Editora Pasteur eBooks” An integrative approach combining medical, nutritional, and lifestyle changes effectively manages female pattern hair loss.
February 2026 in “Psychiatria” This narrative case study examined a 28-year-old medical resident and found that occupational stress and emotional suppression might contribute to the physical manifestation of alopecia areata. Addressing psychological aspects alongside medical treatment could help manage the condition more effectively, especially in high-pressure professions.
February 2026 in “BMJ Open” This source highlights the importance of a multidisciplinary approach, involving medical, mental health, and trichology professionals along with peer support facilitators, in promoting psychological well-being for individuals with alopecia areata.
January 2026 in “Advances in Dermatology and Allergology” In this study, patients with lichen planopilaris and frontal fibrosing alopecia reported a substantial impairment in quality of life and experienced high levels of stress, often considering stress a cause of their condition.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This article explores the pathophysiology of alopecia and reviews various treatment options, including allopathic, homeopathic, naturopathic, cosmeceutical, and ayurvedic approaches, in light of the increasing interest in hair health and the rise in alopecia cases. Results are not reported.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This article explores the various causes of alopecia and provides an overview of treatments such as allopathic, homeopathic, naturopathic, cosmeceutical, and ayurvedic methods, emphasizing recent advancements in addressing hair loss.
January 2026 in “Dermatologic Therapy” This study reports that intramuscular compound betamethasone may offer rapid, short-term reduction in hair shedding for patients with telogen effluvium, particularly within a week, but often requires repeated treatments; only mild side effects were observed.
December 2025 in “Journal of the Korean Society of Cosmetology” This study observed that among adults in their 20s and 30s, deteriorating scalp and hair health increased hair loss stress, which in turn prompted more proactive scalp care behaviors, with hair condition being a stronger motivator than scalp condition.
November 2025 in “Australian Journal of General Practice” This source discusses the aim of the Australian Journal of General Practice to deliver evidence-based information to help Australian general practitioners provide optimal patient care. Results from specific studies are not included.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, both alopecia areata and androgenetic alopecia were found to moderately impact quality of life, affecting emotional and social aspects in patients.
October 2025 in “COGNITIONIS Scientific Journal” This integrative review reports that postpartum telogen effluvium is linked to hormonal changes, stress, and nutritional deficiencies, with management typically involving nutritional support, topical treatments, and psychological support.
October 2025 in “Tạp chí Y Dược học Cần Thơ” This study found that anxiety disorders are relatively common among patients with hair loss, especially in women, highlighting the importance of comprehensive management including psychological support.
October 2025 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Hair loss negatively impacts quality of life, and psychological support can help.
October 2025 in “Indonesian Journal of Global Health Research” In this study, researchers found that nutritional status is the most significant predictor of physical appearance among children and adolescents with cancer, with better nutrition correlating with a more favorable appearance and reducing psychological distress related to body image concerns.
October 2025 in “Reactions Weekly” Finasteride and dutasteride may cause depression and suicidal thoughts.
September 2025 in “Dermatology and Therapy” This study reviewed the burden of alopecia areata in the UAE, noting limited regional data on patient demographics and treatments but highlighting the approval and promising results of the Janus kinase inhibitor baricitinib for managing this condition.
September 2025 in “Journal of the American Academy of Dermatology” Alopecia areata is linked to a higher risk of psychiatric disorders.
August 2025 in “UWE Research Repository (UWE Bristol)” In this study, researchers interviewed women with rosacea to understand its impact on their romantic relationships, revealing challenges with self-esteem, intimacy, and a fear of negative judgment, as well as highlighting the need for supportive partners and open communication to cope with the condition.
August 2025 in “International Journal of Women’s Dermatology” In this case series, restarting Janus kinase inhibitors after pregnancy led to hair regrowth in women with alopecia areata, but highlights the lack of standardized treatment guidelines for those planning pregnancy.
August 2025 in “Annals of Indian Psychiatry” In a cross-sectional study, 46% of patients with androgenetic alopecia were found to have depression of borderline to moderate severity, while 62% reported no impact on their quality of life, emphasizing the need for awareness of psychiatric comorbidities among dermatologists.
July 2025 in “Journal of Case Reports and Scientific Images” This study reports that a patient with severe, treatment-resistant alopecia areata experienced sustained hair regrowth and emotional improvement over 24 months following individualized homeopathic treatment, suggesting homeopathy may be a viable therapeutic option when conventional treatments fail.
June 2025 in “Reactions Weekly” Finasteride may increase the risk of depression and suicidal thoughts.